The oncologic efficacy of extended thoracic resections
- PMID: 36630102
- DOI: 10.1002/jso.27151
The oncologic efficacy of extended thoracic resections
Abstract
Locally invasive lung cancers pose unique challenges for management. Surgical resection of these tumors can pose high morbidity due to the invasion into surrounding structures, including the spine, chest wall, and great vessels. With advances in immunotherapy and chemoradiation, the role for radical resection of these malignancies and associated oncologic outcomes is evolving. This article reviews the current literature of extended thoracic resections with a focus on technical approach, functional outcomes, and oncologic efficacy.
Keywords: extended resection; lung cancer; thoracic oncology; thoracic surgery.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Hare E. Tumor involving certain nerves. Lond Med Gaz. 1838;1:16-18.
-
- Chmielewska I, Stencel K, Kalinka E, Ramlau R, Krawczyk P. Neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer-clinical trials experience. Cancers. 2021;13(20):5048.
-
- Bilfinger T, Keresztes R, Albano D, Nemesure B. Five-year survival among stage IIIA lung cancer patients receiving two different treatment modalities. Med Sci Monit. 2016;22:2589-2594.
-
- Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138-155.
-
- Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(5):497-530.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
